![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
01 Dr. Reddy\'s Laboratories (1)
02 Pharmathen SA (1)
03 Supriya Lifescience (1)
04 Hangzhou Jiuyuan Gene Engineering (1)
05 Hikma Pharmaceuticals (1)
06 Novo Nordisk (16)
07 Savior Lifetec Corporation (1)
08 Wanbang Biopharmaceuticals (1)
01 INJECTABLE;INJECTION (1)
02 INJEKTIONSVÄTSKA, LÖSNING I FÖRFYLLD (1)
03 Injection (3)
04 Injection fluid, resolution in the finished filled pen (1)
05 Liraglutide 6Mg/Ml 3Ml 2 Units Parenteral Use (1)
06 PED (5)
07 Pen Injector (1)
08 SOLUTION (3)
09 SOLUTION FOR INJECTION IN PRE-FILLED (1)
10 SOLUTION;SUBCUTANEOUS (3)
11 Solution For Injection (1)
12 Blank (2)
01 Lead Market Dossiers- Under Development (1)
02 Originator (5)
03 Prescription (3)
04 RX (2)
05 Blank (12)
01 LIRAGLUTIDE (1)
02 SAXENDA (2)
03 Saxenda (3)
04 VICTOZA (2)
05 Victoza (5)
06 XULTOPHY (1)
07 XULTOPHY 100/3.6 (1)
08 Xultophy (1)
09 Xultophy, Inj Lös 100E/ml 3.6 mg/ml (neu), 3 Fertpen 3 ml (1)
10 Blank (6)
01 Canada (3)
02 China (2)
03 Greece (1)
04 India (2)
05 Italy (1)
06 Norway (1)
07 South Africa (5)
08 Sweden (2)
09 Switzerland (1)
10 Taiwan (1)
11 USA (4)